Global mobile diabetes app market size and total download numbers keep growing steadily. There is one service provider group reaping most of the app downloads in the market.
The digital therapeutics (DTx) market has witnessed over 400 collaborations. Solution providers established four types of partnership ecosystems to foster development, aid market entry, and facilitate the integration of DTx.
As 500 partnerships recorded in digital diabetes, there are four types of partnership ecosystems emerged. Building ecosystems is becoming one of the main go-to-market strategies for some digital diabetes solution providers.
Digital diabetes solutions market received approx. $9B USD investments between 2014-2022. Six key service areas stand out as the main recipients of fundings, including one clear winner.
Digital oncology market segment accumulated $8B+ across 150+ funding rounds since 2014. One region emerged as the hub for the investments.
DTx investments peaked at $3B+ in 2021, normalizing in 2022. Four therapy areas secured $500M+ funding since 2021. One disease area emerged as the investment leader.
The number of partnerships in the digital oncology market reached to more than 80 deals in 2022. There are four main partnership areas. One area stands out as the most targeted.
Digital therapeutics (DTx) solutions market keeps evolving and developing, and partnerships play a key role in that. What are the purposes behind these partnerships in the DTx market?
Competing in a mature digital health market like diabetes is no small feat. There are four main strategies to grow a digital diabetes solution business.
The interest for the Automated Insulin Delivery (AID) systems is increasing. The major competitors are making moves to close partnership deals for AID. However, there are at least 4 obstacles that they must overcome to grow their AID business and set themselves apart.